Optical Biopsy of Human Skin in Conjunction With Laser Treatment

NCT00540566 — Completed, 113 participants, University of California, Irvine

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT00540566
StatusCompleted
Study typeObservational
Enrollment113 (Actual)
SponsorUniversity of California, Irvine (Other); collaborators: Beckman Laser Institute University of California Irvine
ConditionsMalignant Melanoma, Merkel Cell Carcinoma, Basal Cell Carcinoma, Squamous Cell Carcinoma, Atypical Nevi, Congenital Nevi, Seborrheic Keratosis, Paget's Disease, Dermatofibroma, Kaposi's Sarcoma, Port Wine Stain, Hemangioma, Tattoos, Scleroderma, Burns
InterventionsOptical Biopsy imaging (Device)
Datesstart 1999-06-01, primary completion 2008-06-01, completion 2008-07-01, first posted 2007-10-08, last updated 2022-10-20
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
All trials for Malignant Melanoma All trials for Merkel Cell Carcinoma All trials of Optical Biopsy imaging

-Summary

This study is to compare the ability of optical biopsy. Research can use light enters the skin, collected, analyzed by the computer, and a picture created for the pathologist to conventional histologic examination compare with the pathologist looking at the piece of tissue through a microscope makes the diagnosis.

Expand all sections  ·  Collapse all

+Detailed description

The Optical measurements provide quantitative optical property values that reflect changes in tissue perfusion, oxygen consumption, and cell/matrix development. Each measurement requires less than 5 minutes to execute. The measurements will be taken before and after skin treatment.This non-invasive, non-contact technique has great potential as a means to diagnose different skin problems without the need to obtain a piece of tissue from the skin.

+Arms and interventions

ArmTypeInterventionsDescription
Optical BiopsyDevice: Optical Biopsy imagingOptical Biopsy imaging
  • Optical Biopsy imaging (Device): Optical Biopsy imaging

+Outcome measures

Primary outcomes

  • normal skin [12 weeks]

+Eligibility

Sex: All, ages: 18 Years to 75 Years, accepts healthy volunteers

Inclusion Criteria:

* Male or female age > 18 years

Exclusion Criteria:

* current participation in any other investigational drug evaluation
* inability to understand and carry out instructions

+Locations (1)

FacilityCityCountryStatus
Beckman Laser Institute, Unversity of California IrvineIrvine, CaliforniaUnited States

+Investigators